Active Biotech AB

BTPC

Company Profile

  • Business description

    Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

  • Contact

    Scheelevagen 22
    P.O. Box 724
    Lund223 63
    SWE

    T: +46 46192000

    E: [email protected]

    https://www.activebiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    5

Stocks News & Analysis

stocks

The 10 best US dividend stocks

These are the top dividend-paying stocks to buy in 2025.
stocks

ASX listed tariff play

Trump’s focus on US steel production may benefit this firm.
stocks

Ask the analyst: How reliant are Guzman shares on international growth?

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,945.6054.800.62%
CAC 407,822.0099.911.29%
DAX 4024,370.93361.551.51%
Dow JONES (US)44,484.49229.710.52%
FTSE 1008,972.6446.090.52%
HKSE24,498.9518.81-0.08%
NASDAQ20,885.65155.160.75%
Nikkei 22539,947.7546.560.12%
NZX 50 Index12,896.898.52-0.07%
S&P 5006,297.3633.660.54%
S&P/ASX 2008,694.3055.300.64%
SSE Composite Index3,516.8313.050.37%

Market Movers